Subscribe to Newsletter

Drug Delivery

Discovery & Development Drug Delivery

Oral Alternatives for Injectable IV Medicines

| Stephanie Vine | 2 min read

Researchers say they have found a method that will allow some large molecules to be administered orally.

Discovery & Development Formulation

Tackling the Nasal Membrane Challenge

| Stephanie Vine | 3 min read

Drugs are very challenging to formulate for delivery across the nasal membrane. An expert gives their view on the issue.

Manufacture Advanced Medicine

Inhalable Gene Therapies? Here’s How They Could Work

| Stephanie Vine | 5 min read

Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.

Discovery & Development Dosage Forms

Going From Benchtop Chemist to CEO: Part 2

| Stephanie Vine | 5 min read

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Discovery & Development Drug Delivery

Squid-Inspired Drug Delivery

| Stephanie Vine | 4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally.

Discovery & Development Dosage Forms

Co-Crystals Shine in Innovation Awards

| 1 min read

Celebrating the winner of our annual Innovation Awards: a service for co-crystal prediction.

Discovery & Development Formulation

Schizophrenia and the Future of Long-Acting Therapeutics

| Stephanie Vine | 5 min read

Long-acting injectables help with adherence, but what if an unfolding pill could provide an oral option?

Discovery & Development Drug Delivery

The Force Meets Oligonucleotides

| Stephanie Vine

Researchers develop a new platform to improve delivery of oligonucleotide therapies to muscle.

Discovery & Development Drug Delivery

RIDE: A New Approach to CRISPR Delivery

| Rob Coker | 2 min read

A new study reports targeted CRISPR delivery in retinal and neurological disease models – without viral vectors.

Discovery & Development Drug Delivery

Nanovesicles: An Approach to Improve Genetic Medicine

| 4 min read

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.


Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register